Tenofovir/Emtricitabine

DRUG11 trials

Sponsors

French National Agency for Research on AIDS and Viral Hepatitis, Dallas VA Medical Center, Bristol-Myers Squibb, Germans Trias i Pujol Hospital, Indiana University

Conditions

ContraceptionHIVHIV InfectionsHIV, Combination TherapyHIV-1 InfectionHIV/AIDSHuman Immunodeficiency Virus

Early Phase 1

Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP

CompletedNCT03197961

Sharon AchillesContraception, HIV/AIDS

Start: 2017-11-17End: 2020-12-01Updated: 2020-12-03

Phase 2

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada

CompletedNCT00528060

French National Agency for Research on AIDS and Viral HepatitisHIV Infections

Start: 2008-01-31End: 2008-11-30Updated: 2011-12-22

Phase IIB Pilot of Atazanavir + Raltegravir

TerminatedNCT00768989

Bristol-Myers SquibbHIV

Start: 2008-11-30End: 2010-05-31Updated: 2012-02-24

Phase 3

Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine

CompletedNCT00808002

Germans Trias i Pujol HospitalHIV Infections

Start: 2009-02-28End: 2011-11-30Updated: 2020-01-31

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

CompletedNCT01003990

Bristol-Myers SquibbHIV

Start: 2002-10-31End: 2016-02-29Updated: 2017-05-11

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

TerminatedNCT01620944

Bristol-Myers SquibbHIV

Start: 2012-07-31End: 2013-01-22Updated: 2024-01-10

Phase 4

Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients

CompletedNCT00677300

Dallas VA Medical CenterHIV Infections

Start: 2009-01-31End: 2012-12-31Updated: 2014-09-08

Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients

CompletedNCT01270802

Indiana UniversityHIV

Start: 2011-04-30End: 2013-04-30Updated: 2013-12-18

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

CompletedNCT01332227

Bristol-Myers SquibbHIV, Combination Therapy

Start: 2011-10-31End: 2014-02-28Updated: 2015-02-19

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

CompletedNCT01772940

Centre Hospitalier Universitaire Saint PierreHIV-1 Infection

Start: 2008-12-31End: 2011-12-31Updated: 2013-08-26

PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5

CompletedNCT02149888

Unity Health TorontoHIV, Human Immunodeficiency Virus

Start: 2014-10-31End: 2016-06-30Updated: 2016-10-17

Related Papers

Acceptability and tolerability of and adherence to HIV preexposure prophylaxis among Toronto gay and bisexual men: a pilot study

CMAJ Open2018-10-018 citations

High HIV risk and syndemic burden regardless of referral source among MSM screening for a PrEP demonstration project in Toronto, Canada.

2018-02-2712 citations

Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.

2013-03-0430 citations